Countries South Korea
Recorded Q4'24 consolidated revenue of KRW 1.26 trillion Recorded FY'24 consolidated revenue of KRW 4.55 trillion Poised for further growth w...
January 23, 2025 | News
GordonMD Global Investments® LP (“GordonMD”), a US-based investment manager focused exclusively on global public and private biopharma...
January 22, 2025 | News
NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Devi...
January 16, 2025 | News
SN BioScience announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administra...
January 13, 2025 | News
Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, ...
January 13, 2025 | News
The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of&...
January 09, 2025 | News
Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise Samsung Biolog...
January 09, 2025 | News
Pneumococcal disease remains a major global health challenge despite the availability of current vaccines This 21-valent pneumococcal conjugate vaccine ...
December 23, 2024 | News
Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium. Macrogen a global healthcare company that specializes in pre...
December 23, 2024 | News
Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics disc...
December 18, 2024 | News
SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder ...
December 17, 2024 | News
LOTTE BIOLOGICS is pleased to announce that James Park will assume the role of Chief Executive Officer, effective December 11, 2024. Mr. Park brings with ...
December 16, 2024 | News
The Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions for Celltrion’s three biosimilar candidates – Eydenz...
December 16, 2024 | News
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing cross-border clinical trial sol...
December 16, 2024 | News
Most Read
Bio Jobs
News
Editor Picks